A Guide to Selecting Your Next Immuno-Oncology Model
As immuno-oncology continues to grow as a therapeutic area, more preclinical research is driven towards assessing immunotherapeutics as single agent or combination therapies. This requires the use of immunocompetent models, a variety of which exist across both mouse analogue and human specific platforms. As each model has their own pros and cons, choosing exactly which one is the most appropriate for a study can prove difficult.
This White Paper covers the main immunocompetent model types with their features, limitations, and major uses, to help select the best model for any given immuno-oncology study.
Download This White Paper To Understand:
- Which model types are available and how to select which model is best suited for your next study
- When mouse analogues (GEMM and syngeneic models) can be utilized versus human specific models (humanized and transiently humanized)
- How a variety of model types allows flexibility in choice, allowing the selection of the most suitable model to meet your study needs